Synthesis, Anti‐Fibrotic Activity, and Density Functional Theory Calculations of Novel Carboxylic Acid Analogs Containing Pyrrole and Imidazole Rings
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70163 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2025. Written by Hiruni Nilshi Indeevarie Abeysiriwardhana and 6 co-authors. Institution: Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju-si, Republic of Korea. Major MEDLINE topics: Imidazoles, Pyrroles, Carboxylic Acids, Antifibrotic Agents. 70 references. Funded by: Ministry of Education, Ministry of SMEs and Startups.
Abstract (original language)
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease with limited treatment options and poor prognosis. Current therapies, Pirfenidone and Nintedanib, slow disease progression but cannot reverse established fibrosis, underscoring the urgent need for innovative strategies. Oxidative stress and hypoxia‐inducible factor‐1α (HIF‐1α) signaling are central to IPF pathogenesis, where the interplay between reactive oxygen species (ROS), TGF‐β1, and stabilized HIF‐1α forms a self‐perpetuating loop that promotes fibroblast activation and extracellular matrix (ECM) deposition. To interrupt this pathological cycle, we rationally designed and synthesized four small molecules, two imidazole‐ and two pyrrole‐based derivatives, with dual antioxidants and HIF‐1α inhibitory potential. Their antioxidant potential was assessed using DPPH and DCFDA assays, while density functional theory (DFT) calculations and ADME profiling confirmed their chemical stability and drug‐likeness. In vitro screening identified compound 2a as the lead candidate based on its superior ability to inhibit HIF‐1α and suppress fibrotic markers, including collagen III, fibronectin, and vimentin, in TGF‐β1‐stimulated A549 and MRC‐5 cells. In vivo, 2a significantly attenuated collagen and fibronectin accumulation in a bleomycin‐induced pulmonary fibrosis model. Mechanistically, 2a inhibited phosphorylation of Smad3 and ERK, implicating modulation of both Smad and non‐Smad pathways in its anti‐fibrotic effects. These findings position compound 2a as a promising dual‐targeted therapeutic candidate for IPF, capable of disrupting the ROS–TGF‐β1–HIF‐1α axis and addressing key unmet clinical needs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju-si, Republic of Korea.
- Department of Biochemistry, School of Medicine, Jeju National University, Jeju-si, Republic of Korea.
- ACHEMBIO Inc, Jeju-si, Republic of Korea.
- Division of Bioscience and Biotechnology, Konkuk University, Seoul, Republic of Korea.
- College of Pharmacy, Jeju National University, Jeju-si, Republic of Korea.
- Department of Veterinary Medicine, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea.
ORCID profiles: Hiruni Nilshi Indeevarie Abeysiriwardhana, Moonjae Cho
Funding
- Ministry of Education
- Ministry of SMEs and Startups
Cite
APA
Abeysiriwardhana, H. N. I., Choi, J. H., Malla, A., Lim, Y., Park, C., Nahm, S. S., & Cho, M. (2025). Synthesis, Anti‐Fibrotic Activity, and Density Functional Theory Calculations of Novel Carboxylic Acid Analogs Containing Pyrrole and Imidazole Rings. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70163
Vancouver
Abeysiriwardhana HNI, Choi JH, Malla A, Lim Y, Park C, Nahm SS, et al. Synthesis, Anti‐Fibrotic Activity, and Density Functional Theory Calculations of Novel Carboxylic Acid Analogs Containing Pyrrole and Imidazole Rings. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70163
BibTeX
@article{Abeysiriwardhana2025,
author = {Abeysiriwardhana, Hiruni Nilshi Indeevarie and Choi, Jin-Hyuk and Malla, Ayusha and Lim, Yoongho and Park, Chulhun and Nahm, Sang-Soep and Cho, Moonjae},
title = {Synthesis, Anti‐Fibrotic Activity, and Density Functional Theory Calculations of Novel Carboxylic Acid Analogs Containing Pyrrole and Imidazole Rings},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70163}
}
EUVIMED